01/16/2023
Recommendation from EPE
Editas (EDIT) enters a restructuring and portfolio reprioritization to focus on hemoglobinopathies and in vivo gene editing. The company is to reduce its workforce by almost 20%. Shares fall.
Market Watchers
Stay Informed, Be Consistent and Realize Profit
Winston-Salem, NC
27107
Be the first to know and let us send you an email when Market Watchers posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.